Luuk Wieske

Research output

Research output per year 2011 2022 2023 2024

• 51 Article
• 3 Review article
• 2 Comment/Letter to the editor
• 2 Erratum/Corrigendum

Research output per year

Research output per year

Search results

• 2022

  SARS-CoV-2 breakthrough infections in patients with immune-mediated inflammatory diseases during the omicron dominant period

  Boekel, L., Besten, Y. R., Hooijberg, F., Wartena, R., Steenhuis, M., Vogelzang, E., Leeuw, M., Atiqi, S., Tas, S. W., Lems, W. F., van Ham, S. M., Eftimov, F., Stalman, E. W., Wieske, L., Kuijpers, T. W., Voskuyl, A. E., van Vollenhoven, R. F., Gerritsen, M., Krieckaert, C., Rispens, T., & 3 othersBoers, M., Nurmohamed, M. T. & Wolbink, G., 1 Nov 2022, In: The Lancet Rheumatology. 4, 11, p. e747-e750 4 p.

  Research output: Contribution to journal › Comment/Letter to the editor › Academic

  Open Access
  12 Citations (Scopus)
• 2021

  Adverse events after first COVID-19 vaccination in patients with autoimmune diseases

  Boekel, L., Kummer, L. Y., van Dam, K. P. J., Hooijberg, F., van Kempen, Z., Vogelzang, E. H., Wieske, L., Eftimov, F., van Vollenhoven, R., Kuijpers, T. W., van Ham, S. M., Tas, S. W., Killestein, J., Boers, M., Nurmohamed, M. T., Rispens, T. & Wolbink, G., 1 Aug 2021, In: The Lancet Rheumatology. 3, 8, p. e542-e545

  Research output: Contribution to journal › Comment/Letter to the editor › Academic

  Open Access
  59 Citations (Scopus)